Google
VCYT — VERACYTE INC (Healthcare >> Diagnostics & Research)
VCYT FAQ
What is VCYT's P/E ratio?
VERACYTE INC (VCYT) currently trades at a P/E ratio of 43.34.
What is VCYT's ROE?
VERACYTE INC reports a Return on Equity (ROE) of 6.55%.
What is VCYT's dividend yield?
VERACYTE INC offers a dividend yield of 0.00%.
What is VCYT's Deepscope Quality Score?
Deepscope rates VCYT's overall financial quality at 77 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy VCYT?
Deepscope's AI Timing Score for VCYT is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does VCYT belong to?
VERACYTE INC is classified under the Healthcare >> Diagnostics & Research sector on the NASDAQ exchange.
|
USD 48.69
Price
0.89
(1.86%)
Day Change
|
|
|---|
VCYT, the overall quality is good ( Quality = 77) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
ROE is relatively low.
Historical ROE is relatively low
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
50% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 60 |
| Magic Formula Rank by ROA |
2326
|
| Magic Formula Rank by ROE |
2326
|
| Magic Formula Rank by ROIC |
2650
|
| Price | 48.69 |
| PBV / Sector |
2.84 / -23.97
|
| Earning Per Share | 1.12 |
| PE / Sector |
43.34 / 36.92
|
| PEG or PE/Growth / Sector |
0.95 / 1.37
|
| Average 1M Daily Value |
52.40 M
|
| Average 1W Daily Value |
62.14 M
|
| Timing Factors |
|
85% |
| Financial Health |
|
37% |
| Ability to Make Profit |
|
66% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-04 09:24:07 |
| Symbol | VCYT |
| Name | VERACYTE INC |
| Sector | Healthcare >> Diagnostics & Research |
| Market | NASDAQ |
| Listed Shares | 79.79 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 3,814.09 / 31,486.64 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 6000 Shoreline Court, South San Francisco, CA, United States, 94080
Phone: 650 243 6300
Website: https://www.veracyte.com
Employees: 755
Description: Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
ME vs SECTOR Healthcare >> Diagnostics & Research
Click a bubble to view stock details · Bubble size represents market capitalization share
